Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas

Oncogene

Volumn 21, Issue 43, 2002, Pages 6598-6605

  Rhee, Chae Seo ^a,b   Sen, Malini ^a   Lu, Desheng ^a   Wu, Christina ^a   Leoni, Lorenzo ^a   Rubin, Jeffrey ^c   Corr, Maripat ^a   Carson, Dennis A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Seoul National University College of Medicine   (South Korea)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Beta catenin; Frizzled; Head and neck squamous cell carcinomas

Indexed keywords

BETA CATENIN; CYCLIN D1; FRIZZLED PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN; PROTEIN FRIZZLED 2; PROTEIN FRIZZLED 5; PROTEIN LEF; PROTEIN WNT 10B; PROTEIN WNT 13; PROTEIN WNT 7A; PROTEN TCF; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT 1 ANTIBODY; WNT PROTEIN; WNT1 PROTEIN; WNT5A PROTEIN;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EPITHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LIGAND BINDING; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; SQUAMOUS CELL CARCINOMA;

ANTIBODIES; CARCINOMA, SQUAMOUS CELL; FRIZZLED RECEPTORS; GLYCOPROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOTHERAPY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROTRANSMITTER; RNA, MESSENGER; TUMOR CELLS, CULTURED; WNT PROTEINS; WNT1 PROTEIN; ZEBRAFISH PROTEINS;

EID: 0037179894     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205920     Document Type: Article

References (22)

1. Aoki M, Hecht A, Kruse U, Kemler R and Vogt PK. (1999). Proc. Natl. Acad. Sci. USA, 96, 139-144.
2. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R and Birchmeier W. (1996). Nature, 382, 638-642.
3. Cadigan KM and Nusse R. (1997). Genes Dev., 11, 3286-3305.
4. Hunter T. (1997). Cell, 88, 333-346.
5. Kim SY, Chu KC, Lee HR, Lee KS and Carey TE. (1997). Acta Otolaryngol., 117, 775-784.
6. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H. (1997). Science, 275, 1784-1787.
7. Ku JL, Kim WH, Lee JH, Park HS, Kim KH, Sung MW and Park JG. (1999). Laryngoscope, 109, 976-982.
8. Landis SH, Murray T, Bolden S and Wingo PA. (1999). CA Cancer J. Clin., 49, 8-31.
9. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M and Gutkind JS. (2000). Oncogene, 19, 3220-3224.
10. Miller JR, Hocking AM, Brown JD and Moon RT. (1999). Oncogene, 18, 7860-7872.
11. Ng JK, Tamura K, Buscher D and Izpisua-Belmonte JC. (1999). Curr. Top. Dev. Biol., 41, 37-66.
12. Nusse R and Varmus HE. (1982). Cell, 31, 99-109.
13. Parkin DM, Pisani P and Ferlay J. (1999). CA Cancer J. Clin., 49, 33-64.
14. Parr BA, Shea MJ, Vassileva G and McMahon AP. (1993). Development, 119, 247-261.
15. Ramsdell AF and Yost HJ. (1998). Trends Genet., 14, 459-465.
16. Riddle RD, Ensini M, Nelson C, Tsuchida T, Jessell TM and Tabin C. (1995). Cell, 83, 631-640.
17. Sagara N, Toda G, Hirai M, Terada M and Katoh M. (1998). Biochem. Biophys. Res. Comm., 252, 117-122.
18. Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Battaro DP, Cumberledge S and Rubin JS. (2000). J. Biol. Chem., 275, 4374-4382.
19. Vogel A, Rodriguez C, Warnken W and Izpisua Belmonte JC. (1995). Nature, 378, 716-720.
20. Whiteside TL, Sung MW, Nagashima S, Chikamatsu K, Okada K and Vujanovic NL. (1998). Clin. Cancer Res., 4, 1135-1145.
21. Yasumura S, Hirabayashi H, Schwartz DR, Toso JF, Johnson JT, Herberman RB and Whiteside TL. (1993). Cancer Res., 53, 1461-1468.
22. Yoganathan TN, Costello P, Chen X, Jabali M, Yan J, Lenng D, Zhang Z, Yee A, Dedhar S and Senghera J. (2000). Biochem. Pharmacol., 60, 1115-1119.